- Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial2022 | Publikace bez příslušnosti k fakultě
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial2012 | 1. lékařská fakulta
- No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE study2017 | 1. lékařská fakulta
- Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting2016 | 3. lékařská fakulta
- Effects of Off-Pump and On-Pump Coronary-Artery Bypass Grafting at 1 Year2013 | 3. lékařská fakulta
- Baseline risk factors of in-hospital mortality after surgery for acute type A aortic dissection: an ERTAAD study2023 | 3. lékařská fakulta
- A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the lower limbs2015 | Lékařská fakulta v Plzni
- A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure2015 | 1. lékařská fakulta
- Dulaglutide and Incident Atrial Fibrillation or Flutter in patients with type 2 Diabetes; a post-hoc analysis from the REWIND Randomized Trial2022 | Publikace bez příslušnosti k fakultě
- A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease2009 | Lékařská fakulta v Hradci Králové, 3. lékařská fakulta, 2. lékařská fakulta
- Psoriáza a nežádoucí vlivy na těhotenství: systematický přehled observačních studií2017 | Lékařská fakulta v Plzni
- Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection2016 | 1. lékařská fakulta
- Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial2015 | 1. lékařská fakulta
- A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the upper extremity2015 | Lékařská fakulta v Hradci Králové
- Geographic variations in the PARADIGM-HF heart failure trial2016 | 1. lékařská fakulta
- Characteristics and outcomes of patients requiring bailout use of glycoprotein IIb/IIIa inhibitors for thrombotic complications of percutaneous coronary intervention: An analysis from the CHAMPION PHOENIX trial2019 | Publikace bez příslušnosti k fakultě
- Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapy2014 | Lékařská fakulta v Hradci Králové
- Results of a curtailed randomized controlled trial, evaluating the efficacy and safety of azimilide in patients with implantable cardioverter-defibrillators: The SHIELD-2 trial2017 | Lékařská fakulta v Hradci Králové
- Predictors of mortality after atrial correction of transposition of the great arteries2022 | 2. lékařská fakulta, Ústřední knihovna
- Off-pump or on-pump coronary-artery bypass grafting at 30 days2012 | 3. lékařská fakulta
- Polypill Strategy in Secondary Cardiovascular Prevention2022 | 1. lékařská fakulta
- Off-Pump or On-Pump Coronary-Artery Bypass Grafting at 30 Days2012 | Lékařská fakulta v Hradci Králové
- Radial versus femoral access for elderly patients with acute coronary syndrome undergoing coronary angiography and intervention: insights from the RIVAL trial2015 | 3. lékařská fakulta
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes2017 | 2. lékařská fakulta
- The efficacy and safety of dapagliflozin in women and men with type 2 diabetes mellitus2021 | Publikace bez příslušnosti k fakultě
- Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids)2019 | Publikace bez příslušnosti k fakultě
- Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis2020 | 1. lékařská fakulta
- Estimating Time to ESRD in Children With CKD2018 | 2. lékařská fakulta
- Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation2020 | Lékařská fakulta v Hradci Králové, 1. lékařská fakulta, 3. lékařská fakulta, Lékařská fakulta v Plzni, Ústřední knihovna
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial2019 | Publikace bez příslušnosti k fakultě